Earnings call: Stryker showcases robust Q1 growth, raises full-year outlook

Stryker Corporation (NYSE:
[SYK](/equities/stryker)) has reported a strong first quarter with a 10% organic sales growth, driven primarily by its MedSurg and Neurotechnology segments. The company has raised its full-year organic sales growt
Read more...